Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in Kenya

Conditions studied

Breast Carcinoma

About this study

This clinical trial develops and studies how well mobile health (m-Health) patient navigation (PN) strategies work to improve screening and the early detection of breast cancer in women accessing primary care clinics in Kenya. Although highly curable, breast cancer kills thousands of women in developing countries yearly. Mammography (MMG) is used for the early detection of breast cancer by creating a picture of the breast using film or a computer. Despite the availability of MMG in all 47 counties in Kenya, screening remains low in eligible women. Early detection of breast cancer may also be improved through access to high quality clinical breast exams (CBE). However, primary care providers in Kenya face barriers to incorporating CBE into practice, including limited patient awareness of breast cancer screening. m-Health uses applications on mobile phones to deliver PN directly to the patients. The PN strategies in this study include digital platforms and tools to help with education, reminders, navigation, and motivation around breast cancer screening. This may improve screening and the early detection of breast cancer in women accessing primary care clinics in Kenya.

Interventions

• Other: Best Practice — Receive EUC
• Other: Discussion — Complete a focus group
• Other: Interview - Stakeholder — Complete stakeholder interview
• Other: Interview - Key Informant — Complete key informant interview
• Other: Interview - Ancillary studies — Ancillary studies
• Behavioral: Patient Navigation - C Components — Receive adapted m-Health PN strategy C components
• Behavioral: Patient Navigation - B components — Receive adapted m-Health PN strategy B components
• Behavioral: Patient Navigation - A components — Receive adapted m-Health PN strategy A components
• Other: Survey Administration — Complete EBI adaptation and implementation surveys
• Other: Survey Administration - Ancillary studies — Ancillary studies

Primary outcomes

• Adapted evidence-based intervention (EBI) delivery strategies (Aim 1) (Up to 2 years)
• Health system resources, training, and requirements for EBI implementation (Aim 2) (Up to 4 years)
• Access to screening mammography (MMG) for eligible asymptomatic women (Aim 3) (Up to 6 months)
• Access to diagnostic MMG or breast ultrasound for women who have a breast abnormality identified on clinical breast examination offered at the clinic (Aim 3) (Up to 6 months)

Eligibility information

Study locations

• Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia 30322 United States